Related Experiment Video
Updated: Feb 20, 2026

10:14
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
4.3K
INTRARETINAL HYPERREFLECTIVE FOCI IN BEST VITELLIFORM MACULAR DYSTROPHY
Maurizio Battaglia Parodi1, Francesco Romano1, Riccardo Sacconi2
1Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy.
Retina (Philadelphia, Pa.)
|October 25, 2017
Summary
Hyperreflective foci (HF) detected via spectral domain optical coherence tomography are prevalent in Best vitelliform macular dystrophy (BVMD). Increased HF correlate with disease progression and visual acuity decline, suggesting HF as a potential BVMD biomarker.
Area of Science:
- Ophthalmology
- Medical Imaging
- Genetics
Background:
- Best vitelliform macular dystrophy (BVMD) is an inherited macular disease.
- Spectral domain optical coherence tomography (SD-OCT) is crucial for visualizing retinal structures.
- Hyperreflective foci (HF) are potential indicators of retinal pathology.
Purpose of the Study:
- To investigate the presence and characteristics of HF in BVMD patients using SD-OCT.
- To correlate HF findings with different stages of BVMD.
- To assess the relationship between HF and best-corrected visual acuity (BCVA).
Main Methods:
- Prospective cross-sectional study of BVMD patients and controls.
- Ophthalmologic examination including BCVA and SD-OCT.
- Identification and quantification of intraretinal HF in relation to disease stage.
Main Results:
- HF were present in 83% of BVMD eyes, notably in later stages (Stages 4 & 5).
- HF were predominantly small and located in the outer nuclear layer, often in the macula.
- A significant increase in HF was observed in Stage 4 compared to earlier stages, and BCVA worsened with increasing HF count.
Conclusions:
- SD-OCT effectively identifies HF in BVMD.
- HF presence and number correlate with BVMD stage and severity.
- HF may serve as a valuable biomarker for monitoring BVMD progression.

